Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells

Kuan Chou Chen, Chiung Chi Peng, Robert Y. Peng, Ching Hua Su, Han Sun Chiang, Jr Hung Yan, Hsiu Mei Hsieh-Li

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Antrodia camphorata (AC), a precious and unique folkloric medicinal mushroom enriched in polyphenolics, isoflavonoids, triterpenoids, and polysaccharides, has been diversely used in Formosa (Taiwan) since the 18th century. In this study, prostate cancer (PCa) cell lines PC-3 (androgen independent) and LNCaP (androgen responsive) were treated with AC crude extract (ACCE) at 50-200 μg/mL, respectively, for 48 h. At the minimum effective dose 150 μg/mL, LNCaP showed a G1/S phase arrest with significant apoptosis. Such dose-dependent behavior of LNCaP cells in response to ACCE was confirmed to proceed as Akt → p53 → p21 → CDK4/cyclin D1 → G1/S-phase arrest → apoptosis, which involved inhibiting cyclin D1 activity and preventing pRb phosphorylation. In contrast, being without p53, PC-3 cells showed a G2/M-phase arrest mediated through pathway p21 → cyclin B1/Cdc2 → G2/M-phase arrest, however, with limited degree of apoptosis, implicating that ACCE is able to differentially inhibit the growth of different PCa cells by modulating different cell cycle signaling pathways. We conclude that this unique Formosan mushroom, A. camphorata, due to its nontoxicity, might be used as a good adjuvant anticancer therapy for prostate cancers despite its androgen-responsive behaviors, which has long been a serious drawback often encountered clinically in hormonal refractory cases treated by antihormonal therapies and chemotherapeutics.

Original languageEnglish
Pages (from-to)111-121
Number of pages11
JournalNutrition and Cancer
Volume57
Issue number1
DOIs
Publication statusPublished - 2007 Jan 1

Fingerprint

Antrodia
Agaricales
Complex Mixtures
Androgens
Prostatic Neoplasms
G2 Phase
Cyclin D1
G1 Phase
Apoptosis
Taiwan
S Phase
Cell Division
Cyclin G1
Cyclin B1
Polysaccharides
Cell Cycle
Phosphorylation
Cell Line
Therapeutics
Growth

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Nutrition and Dietetics
  • Cancer Research

Cite this

Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells. / Chen, Kuan Chou; Peng, Chiung Chi; Peng, Robert Y.; Su, Ching Hua; Chiang, Han Sun; Yan, Jr Hung; Hsieh-Li, Hsiu Mei.

In: Nutrition and Cancer, Vol. 57, No. 1, 01.01.2007, p. 111-121.

Research output: Contribution to journalArticle

Chen, Kuan Chou ; Peng, Chiung Chi ; Peng, Robert Y. ; Su, Ching Hua ; Chiang, Han Sun ; Yan, Jr Hung ; Hsieh-Li, Hsiu Mei. / Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells. In: Nutrition and Cancer. 2007 ; Vol. 57, No. 1. pp. 111-121.
@article{ca05045ef742461691ae3c74f7688b05,
title = "Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells",
abstract = "Antrodia camphorata (AC), a precious and unique folkloric medicinal mushroom enriched in polyphenolics, isoflavonoids, triterpenoids, and polysaccharides, has been diversely used in Formosa (Taiwan) since the 18th century. In this study, prostate cancer (PCa) cell lines PC-3 (androgen independent) and LNCaP (androgen responsive) were treated with AC crude extract (ACCE) at 50-200 μg/mL, respectively, for 48 h. At the minimum effective dose 150 μg/mL, LNCaP showed a G1/S phase arrest with significant apoptosis. Such dose-dependent behavior of LNCaP cells in response to ACCE was confirmed to proceed as Akt → p53 → p21 → CDK4/cyclin D1 → G1/S-phase arrest → apoptosis, which involved inhibiting cyclin D1 activity and preventing pRb phosphorylation. In contrast, being without p53, PC-3 cells showed a G2/M-phase arrest mediated through pathway p21 → cyclin B1/Cdc2 → G2/M-phase arrest, however, with limited degree of apoptosis, implicating that ACCE is able to differentially inhibit the growth of different PCa cells by modulating different cell cycle signaling pathways. We conclude that this unique Formosan mushroom, A. camphorata, due to its nontoxicity, might be used as a good adjuvant anticancer therapy for prostate cancers despite its androgen-responsive behaviors, which has long been a serious drawback often encountered clinically in hormonal refractory cases treated by antihormonal therapies and chemotherapeutics.",
author = "Chen, {Kuan Chou} and Peng, {Chiung Chi} and Peng, {Robert Y.} and Su, {Ching Hua} and Chiang, {Han Sun} and Yan, {Jr Hung} and Hsieh-Li, {Hsiu Mei}",
year = "2007",
month = "1",
day = "1",
doi = "10.1080/01635580701268360",
language = "English",
volume = "57",
pages = "111--121",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "1",

}

TY - JOUR

T1 - Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells

AU - Chen, Kuan Chou

AU - Peng, Chiung Chi

AU - Peng, Robert Y.

AU - Su, Ching Hua

AU - Chiang, Han Sun

AU - Yan, Jr Hung

AU - Hsieh-Li, Hsiu Mei

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Antrodia camphorata (AC), a precious and unique folkloric medicinal mushroom enriched in polyphenolics, isoflavonoids, triterpenoids, and polysaccharides, has been diversely used in Formosa (Taiwan) since the 18th century. In this study, prostate cancer (PCa) cell lines PC-3 (androgen independent) and LNCaP (androgen responsive) were treated with AC crude extract (ACCE) at 50-200 μg/mL, respectively, for 48 h. At the minimum effective dose 150 μg/mL, LNCaP showed a G1/S phase arrest with significant apoptosis. Such dose-dependent behavior of LNCaP cells in response to ACCE was confirmed to proceed as Akt → p53 → p21 → CDK4/cyclin D1 → G1/S-phase arrest → apoptosis, which involved inhibiting cyclin D1 activity and preventing pRb phosphorylation. In contrast, being without p53, PC-3 cells showed a G2/M-phase arrest mediated through pathway p21 → cyclin B1/Cdc2 → G2/M-phase arrest, however, with limited degree of apoptosis, implicating that ACCE is able to differentially inhibit the growth of different PCa cells by modulating different cell cycle signaling pathways. We conclude that this unique Formosan mushroom, A. camphorata, due to its nontoxicity, might be used as a good adjuvant anticancer therapy for prostate cancers despite its androgen-responsive behaviors, which has long been a serious drawback often encountered clinically in hormonal refractory cases treated by antihormonal therapies and chemotherapeutics.

AB - Antrodia camphorata (AC), a precious and unique folkloric medicinal mushroom enriched in polyphenolics, isoflavonoids, triterpenoids, and polysaccharides, has been diversely used in Formosa (Taiwan) since the 18th century. In this study, prostate cancer (PCa) cell lines PC-3 (androgen independent) and LNCaP (androgen responsive) were treated with AC crude extract (ACCE) at 50-200 μg/mL, respectively, for 48 h. At the minimum effective dose 150 μg/mL, LNCaP showed a G1/S phase arrest with significant apoptosis. Such dose-dependent behavior of LNCaP cells in response to ACCE was confirmed to proceed as Akt → p53 → p21 → CDK4/cyclin D1 → G1/S-phase arrest → apoptosis, which involved inhibiting cyclin D1 activity and preventing pRb phosphorylation. In contrast, being without p53, PC-3 cells showed a G2/M-phase arrest mediated through pathway p21 → cyclin B1/Cdc2 → G2/M-phase arrest, however, with limited degree of apoptosis, implicating that ACCE is able to differentially inhibit the growth of different PCa cells by modulating different cell cycle signaling pathways. We conclude that this unique Formosan mushroom, A. camphorata, due to its nontoxicity, might be used as a good adjuvant anticancer therapy for prostate cancers despite its androgen-responsive behaviors, which has long been a serious drawback often encountered clinically in hormonal refractory cases treated by antihormonal therapies and chemotherapeutics.

UR - http://www.scopus.com/inward/record.url?scp=34249888778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249888778&partnerID=8YFLogxK

U2 - 10.1080/01635580701268360

DO - 10.1080/01635580701268360

M3 - Article

C2 - 17516868

AN - SCOPUS:34249888778

VL - 57

SP - 111

EP - 121

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 1

ER -